Clinical outcomes after viraemia among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy in South Africa (2023)
Attributed to:
Addressing challenges in scaling up TB and HIV treatment integration in public health settings in South Africa
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ofid/ofad583
Publication URI: http://dx.doi.org/10.1093/ofid/ofad583
Type: Journal Article/Review
Parent Publication: Open Forum Infectious Diseases